A phase I study of sonepcizumab (S), a humanized monoclonal antibody to sphingosine-1-phosphate (S1P), in patients with advanced solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 2560-2560 ◽  
Author(s):  
M. S. Gordon ◽  
R. Just ◽  
L. S. Rosen ◽  
A. Dorr
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Humanized Monoclonal Antibody ◽  
Sphingosine 1 Phosphate

scholarly journals Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors

2017 ◽  
Vol 17 (1) ◽  
pp. 215-221 ◽  
Author(s):  
Elaine T. Lam ◽  
S. Gail Eckhardt ◽  
Wells Messersmith ◽  
Antonio Jimeno ◽  
Cindy L. O'Bryant ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

scholarly journals A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors

2019 ◽  
Vol 37 (5) ◽  
pp. 1061-1074 ◽  
Author(s):  
Toshihiko Doi ◽  
Takeshi Aramaki ◽  
Hirofumi Yasui ◽  
Kei Muro ◽  
Masafumi Ikeda ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

scholarly journals A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors

2014 ◽  
Vol 21 (6) ◽  
pp. 1281-1288 ◽  
Author(s):  
Luis A. Diaz ◽  
Christina M. Coughlin ◽  
Susan C. Weil ◽  
Jean Fishel ◽  
Mrinal M. Gounder ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors
Sign in / Sign up

Export Citation Format

Share Document